A
Adi Wilf-Yarkoni
Researcher at Rabin Medical Center
Publications - 2
Citations - 54
Adi Wilf-Yarkoni is an academic researcher from Rabin Medical Center. The author has contributed to research in topics: Exacerbation & Myasthenia gravis. The author has an hindex of 2, co-authored 2 publications receiving 11 citations. Previous affiliations of Adi Wilf-Yarkoni include Tel Aviv University.
Papers
More filters
Journal ArticleDOI
Safety of the BNT162b2 COVID-19 vaccine in multiple sclerosis (MS): Early experience from a tertiary MS center in Israel.
Itay Lotan,Itay Lotan,Adi Wilf-Yarkoni,Adi Wilf-Yarkoni,Yitzhak Friedman,Yitzhak Friedman,Hadas Stiebel-Kalish,Hadas Stiebel-Kalish,Israel Steiner,Israel Steiner,Mark A. Hellmann,Mark A. Hellmann +11 more
TL;DR: In this paper, the authors report real-life safety data of the BNT162b2 COVID-19 vaccine in a cohort of MS patients, and an anonymous survey was distributed to 425 MS patients.
Journal ArticleDOI
Exacerbation of myasthenia gravis following corticosteroid treatment: what is the evidence? A systematic review
Itay Lotan,Itay Lotan,Mark A. Hellmann,Mark A. Hellmann,Adi Wilf-Yarkoni,Adi Wilf-Yarkoni,Israel Steiner,Israel Steiner +7 more
TL;DR: The prevalence of clinical exacerbation following CS treatment, its’ severity and relation to the type and dose of CS are determined, and the rate of MG exacerbation is highest with the administration of cortisone, intermediate with prednisone, and lowest with methylprednisolone.